Huiyu Lu

411 total citations
29 papers, 303 citations indexed

About

Huiyu Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Huiyu Lu has authored 29 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Huiyu Lu's work include Tracheal and airway disorders (3 papers), Cancer Cells and Metastasis (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Huiyu Lu is often cited by papers focused on Tracheal and airway disorders (3 papers), Cancer Cells and Metastasis (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Huiyu Lu collaborates with scholars based in China, United States and Norway. Huiyu Lu's co-authors include Xiaoyan Gao, Hong‐Lin Chen, Bing Zhang, Lixin Zhang, Lixin Zhang, T.H. Cheung, Tony K.H. Chung, S.K. Lam, Yahui Shen and Lixin Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Medicine and European Journal of Medicinal Chemistry.

In The Last Decade

Huiyu Lu

26 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huiyu Lu China	11	144	120	82	76	35	29	303
James J. Saller United States	8	142 1.0×	119 1.0×	75 0.9×	46 0.6×	33 0.9×	25	275
Xiangshan Yang China	12	76 0.5×	133 1.1×	70 0.9×	72 0.9×	52 1.5×	21	295
Jörg Kumbrink Germany	10	108 0.8×	90 0.8×	80 1.0×	89 1.2×	14 0.4×	37	325
Feiying Gu China	10	106 0.7×	133 1.1×	94 1.1×	55 0.7×	25 0.7×	11	316
Alexandra H. Besser United States	5	114 0.8×	124 1.0×	32 0.4×	95 1.3×	43 1.2×	6	287
Elsa M. Li-Ning-Tapia United States	5	129 0.9×	78 0.7×	146 1.8×	97 1.3×	48 1.4×	6	313
Huanlei Wu China	10	80 0.6×	201 1.7×	86 1.0×	124 1.6×	23 0.7×	15	319
Meifang Xu China	11	129 0.9×	97 0.8×	43 0.5×	77 1.0×	25 0.7×	30	286
Ji‐Hye Oh South Korea	9	92 0.6×	91 0.8×	59 0.7×	72 0.9×	14 0.4×	14	220
Fatma Althoubaity Saudi Arabia	6	86 0.6×	109 0.9×	42 0.5×	93 1.2×	22 0.6×	10	253

Countries citing papers authored by Huiyu Lu

Since Specialization

Citations

This map shows the geographic impact of Huiyu Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiyu Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiyu Lu more than expected).

Fields of papers citing papers by Huiyu Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiyu Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiyu Lu. The network helps show where Huiyu Lu may publish in the future.

Co-authorship network of co-authors of Huiyu Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Huiyu Lu. A scholar is included among the top collaborators of Huiyu Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiyu Lu. Huiyu Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Ru, Yujing Huang, Huiyu Lu, et al.. (2025). Design, synthesis and biological evaluation of novel platelet-derived growth factor receptor-α (PDGFR-α) inhibitors based on 4-anilinoquinoline and 4-anilinoquinazoline scaffolds. European Journal of Medicinal Chemistry. 298. 118015–118015.

Zhang, Jianzhong, et al.. (2025). Bruton’s tyrosine kinase (BTK) inhibitors: an updated patent review (2019–2024). Expert Opinion on Therapeutic Patents. 35(10). 1073–1097.

Zhou, Yuliang, et al.. (2021). The efficacy and safety of acupuncture in the treatment of erectile dysfunction. Medicine. 100(21). e25892–e25892. 4 indexed citations

Gao, Xiaoyan, et al.. (2021). Expression and clinical significance of AURKB gene in lung adenocarcinoma. Medicine. 100(31). e26439–e26439. 6 indexed citations

Zhou, Yuliang, et al.. (2021). Effectiveness of acupuncture for asthenozoospermia. Medicine. 100(17). e25711–e25711. 3 indexed citations

Lu, Huiyu, et al.. (2019). Implantation of 125I radioactive seeds via c-TBNA combined with chemotherapy in an advanced non-small-cell lung carcinoma patient. BMC Pulmonary Medicine. 19(1). 205–205. 5 indexed citations

Lu, Huiyu, et al.. (2018). MerTK Downregulates Lipopolysaccharide-Induced Inflammation Through SOCS1 Protein but Does Not Affect Phagocytosis of Escherichia coli in Macrophages. Inflammation. 42(1). 113–123. 12 indexed citations

Zhang, Bing, et al.. (2018). Long non-coding RNA EPIC1 promotes human lung cancer cell growth. Biochemical and Biophysical Research Communications. 503(3). 1342–1348. 45 indexed citations

Lu, Huiyu, et al.. (2016). k-RAS mutations in non-small cell lung cancer patients treated with TKIs among smokers and non-smokers: a meta-analysis. Współczesna Onkologia. 2(2). 124–129. 3 indexed citations

10.

Yu, Hong, et al.. (2016). Primary pulmonary synovial sarcoma presenting with a large lump mass in the left upper mediastinum: A case report. Experimental and Therapeutic Medicine. 11(6). 2395–2398. 3 indexed citations

11.

Gao, Xiaoyan, et al.. (2015). siRNA targeting of Trop2 suppresses the proliferation and invasion of lung adenocarcinoma H460 cells. Experimental and Therapeutic Medicine. 10(2). 429–434. 9 indexed citations

12.

Gao, Xiaoyan, et al.. (2015). Bilateral pleural effusion as an initial manifestation of multiple myeloma: A case report and literature review. Experimental and Therapeutic Medicine. 9(3). 1040–1042. 5 indexed citations

13.

Chen, Hong‐Lin, et al.. (2014). Comparison of Glasgow prognostic score and prognostic index in patients with advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 141(3). 563–568. 18 indexed citations

14.

Lu, Huiyu, et al.. (2014). Isolation, cultivation and identification of human lung adenocarcinoma stem cells. Oncology Letters. 9(1). 47–54. 33 indexed citations

15.

Gao, Xiaoyan, et al.. (2014). Diagnosis and management of a patient with primary pulmonary diffuse large B-cell lymphoma: A case report and review of the literature. Experimental and Therapeutic Medicine. 8(3). 797–800. 12 indexed citations

16.

Gao, Xiaoyan, et al.. (2013). Diagnosis and management of an elderly patient with severe tracheomalacia: A case report and review of the literature. Experimental and Therapeutic Medicine. 6(3). 765–768. 11 indexed citations

17.

Gao, Xiaoyan, et al.. (2013). Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma. Oncology Letters. 6(2). 375–380. 35 indexed citations

18.

Lu, Huiyu, Yuejiao Huang, Hui Shi, et al.. (2013). Expression and prognostic role of c-Myb as a novel cell cycle protein in esophageal squamous cell carcinoma. Clinical & Translational Oncology. 15(10). 796–801. 12 indexed citations

19.

Lu, Huiyu, et al.. (2009). Effects of Huaiqihuang on Proteinuria and Nephrin, Podocin in Rats With IgA Nephropathy. 5(5). 458–465. 1 indexed citations

20.

Cheung, T.H., et al.. (1995). Prevalence and Significance of HER-2/neuAmplification in Epithelial Ovarian Cancer. Gynecologic and Obstetric Investigation. 40(3). 209–212. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact